Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 45 (ZNF45) is a member of the zinc finger protein family, which are defined by their characteristic zinc finger motifs that coordinate zinc ions and typically mediate DNA, RNA, or protein interactions[1]. ZNF45 is predicted to act as a DNA-binding transcription factor that regulates the expression of target genes by modulating DNA-templated transcription, and is predominantly located in the nucleoplasm[2][3]. Diseases associated with ZNF45 include retinal macular dystrophies. No evidence exists that ZNF45 functions as a therapeutic target, nor are its direct drug interactions, biomarker utility, or safety concerns currently documented[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 45 (ZNF45).